QT Imaging Holdings, Inc.
General ticker "QTI" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $65.0M (TTM average)
QT Imaging Holdings, Inc. does not follow the US Stock Market performance with the rate: -34.4%.
Estimated limits based on current volatility of 4.2%: low 2.08$, high 2.26$
Factors to consider:
- Earnings expected soon, date: 2026-11-10 amc
- Total employees count: 32 (+52.4%) as of 2025
- US accounted for 99.8% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Operating losses, Inability to commercialize products, Need additional capital, Limited operating history, Lack of market acceptance
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.50$, 9.33$]
- 2026-12-31 to 2027-12-31 estimated range: [1.55$, 6.08$]
Financial Metrics affecting the QTI estimates:
- Positive: with PPE of -4.2 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: 2.76 < Interest expense per share per price, % of 4.31
- Negative: Investing cash flow per share per price, % of -0.20 <= -0.07
- Negative: negative Industry operating income (median)
- Negative: 24.07 < Shareholder equity ratio, % of 28.00 <= 33.49
- Negative: -0.26 < Industry inventory ratio change (median), % of -0.23
Short-term QTI quotes
Long-term QTI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.04MM | $4.88MM | $18.93MM |
| Operating Expenses | $5.05MM | $17.06MM | $23.36MM |
| Operating Income | $-5.01MM | $-12.18MM | $-4.44MM |
| Non-Operating Income | $-1.09MM | $3.18MM | $-16.65MM |
| Interest Expense | $0.54MM | $4.50MM | $2.64MM |
| R&D Expense | $1.49MM | $3.27MM | $3.94MM |
| Income(Loss) | $-6.10MM | $-9.00MM | $-21.08MM |
| Taxes | $0.00MM | $-0.02MM | $-0.00MM |
| Net Income(Loss)* | $-6.10MM | $-8.98MM | $-21.08MM |
| Stockholders Equity | $-5.31MM | $-9.54MM | $6.45MM |
| Inventory | $0.00MM | $3.14MM | $5.03MM |
| Assets | $6.71MM | $6.09MM | $23.02MM |
| Operating Cash Flow | $-2.65MM | $-10.03MM | $-8.96MM |
| Capital expenditure | $0.01MM | $0.09MM | $0.12MM |
| Investing Cash Flow | $-0.01MM | $-0.09MM | $-0.12MM |
| Financing Cash Flow | $2.37MM | $11.13MM | $18.35MM |
| Earnings Per Share** | $-1.92 | $-2.13 | $-2.01 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.